 |
市場調查報告書
商品編碼
1149865
糖生物學市場：按產品類型、應用、最終用戶、地區劃分——規模、份額、展望、機會分析2022-2030Glycobiology Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
價格
簡介目錄
糖生物學是研究聚醣和糖基化生物分子（如醣脂、糖蛋白和糖基化小分子）的科學分支。聚醣在生活的方方面面無處不在。脂質、蛋白質、代謝物和核酸等生物分子與聚醣結構的結合極大地影響了它們的理化性質、亞細胞定位、免疫原性、藥代動力學和藥效學。
所有細胞和許多蛋白質（包括糖蛋白）都覆蓋著密集而復雜的共價連接聚醣陣列（稱為寡糖或聚醣）。這些聚醣的生物學作用在構建複雜的多細胞器官和生物體的過程中尤為重要，這些過程需要細胞之間以及與周圍細胞外基質的相互作用。大多數類型的聚醣存在於細胞表面和分泌的大分子中。此外，簡單、快速代謝的蛋白質結合糖鏈在細胞核和細胞質中含量豐富，並起到調節開關的作用。
聚醣是多種多樣的複雜分子，其功能由其獨特的結構決定。聚醣結構需要有效的□促工具和分析技術，並且可以與特定功能相關聯。聚醣調節蛋白質和細胞的粘附。免疫系統主要通過碳水化合物-蛋白質相互作用發揮作用，突出了碳水化合物在生理學、病原體識別、癌症和自身免疫性疾病中的重要性。
市場動態
推動糖生物學市場增長的關鍵因素包括採用無機增長策略，例如市場參與者的收購。例如，2018 年 6 月，美國生命科學公司安捷倫科技收購了聚醣分析、試劑和試劑盒的私營供應商 ProZyme Inc.。此次收購將擴大公司的糖生物學產品組合
這項研究的主要特點
- 本報告對全球糖生物學市場進行了深入分析，提供了以 2021 年為基準年的預測期 (2022-2030) 的市場規模和復合年增長率 (CAGR%)。
- 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
- 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
- 根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數，介紹全球糖生物學市場的主要參與者概況。
- 本研究涵蓋的主要公司包括 Tracxn Technologies Limited、Agilent Technologies, Inc.、Blirt.eu、Takara Bio Inc.、Bio-Techne、Bruker Corporation、Thermo Fisher Scientific Inc.、Shimadzu Corporation、New England Biolabs ., Waters.co., Merck KGaA, Palleon Pharmaceuticals, Asparia Glycomics, RayBiotech Life, Inc., Z Biotech, LLC., Chemily Glycoscience, Lectenz Bio, 2BScientific, and Glycodiag
- 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
- 《全球糖生物學市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
- 利益相關者可以通過用於分析全球糖生物學市場的各種戰略矩陣來促進決策制定。
內容
第 1 章目的和先決條件
- 調查目的
- 先決條件
- 縮寫說明
第二章市場展望
- 報告內容
- 市場定義和範圍
- 執行摘要
- 按產品類型劃分的市場概況
- 市場概況：按應用分類
- 市場概況：按最終用戶分類
- 市場概況：按地區
- 連貫機會圖 (COM)
第3章市場動態、規律及趨勢分析
- 市場動態
- 司機
- 約束因素
- 市場機會
- 影響分析
- 產品發布
- 監管情景
- 主要發展狀況
- 害蟲分析
第 4 章全球糖生物學市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 對醫療保健行業的總體影響
- 對供需的影響
- COVID-19 對市場的影響
第 5 章全球糖生物學市場：按產品類型，2017-2030
- 設備
- □
- 糖甘□
- GlcNAc 轉移□
- GalNAc 轉移□
- 巖藻糖基轉移□
- 半乳糖基轉移□
- 碳水化合物激□
- 其他
- 消耗品
- 試劑和試劑盒
第 6 章全球糖生物學市場應用，2017-2030
- 診斷用途
- 工業應用
- 治療用途
- 藥物發現和藥物開發
- 其他
第 7 章最終用戶的全球糖生物學市場，2017-2030
- 研究所
- 醫院
- 診斷中心
- 生物製藥公司
- 其他
第 8 章按地區分列的全球糖生物學市場，2017-2030
- 北美
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲地區
- 歐洲
- 英國
- 德國
- 意大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲地區
- 亞太地區
- 中國
- 印度
- 日本
- 東盟
- 澳大利亞
- 韓國
- 其他亞太地區
- 中東
- 海灣合作委員會
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中非
- 南非
第9章競爭格局
- Tracxn Technologies Limited
- Agilent Tecnologies, Inc
- Blirt.eu
- Takara Bio Inc.
- Bio-Techne
- Bruker Corporation
- Thermo Fisher Scientific Inc
- Shimadzu Corporation
- New England Biolabs.
- Waters.co.
- Merck KGaA
- Palleon Pharmaceuticals
- Asparia Glycomics
- RayBiotech Life, Inc
- Z Biotech, LLC
- Chemily Glycoscience
- Lectenz Bio,
- 2BScientific
- Glycodiag
第 10 章
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI3639
Glycobiology is the branch of science which deals with the study of Glycan and glycan-modified biomolecules such as glycolipids, glycoproteins and glycosylated small molecules collectively referred to as sugar molecules. Glycan are universal in all aspects of life. The binding of carbohydrate structures to biomolecules, including lipids, proteins, metabolites, and nucleic acids, can profoundly affect their physicochemical properties, subcellular localization, immunogenicity, and pharmacokinetics and pharmacodynamics.
All cells and many proteins such as glycoproteins are covered with dense and complex arrays of covalently linked sugar chains (called oligosaccharides or glycan). The biological roles of these glycan are of particular importance in the assembly of complex multicellular organs and organisms, processes that require interactions between cells and with the surrounding extracellular matrix. Most classes of glycan are found on the surface of cells and secreted macromolecules. In addition, simple, rapidly metabolizing protein-bound glycan are abundant in the nucleus and cytoplasm, where they function as regulatory switches.
Glycan are diverse and complex molecules whose functions are determined by their unique structures. Glycan structures requires effective enzymatic tools and analytical techniques and can be associated with specific functions. Glycosylation defines the adhesive properties of proteins and cells. The immune system functions primarily through carbohydrate-protein interactions, highlighting the importance of carbohydrates in physiology, pathogen recognition, cancer, and autoimmune diseases.
Market Dynamics
Major factors driving growth of the glycobiology market include adoption of inorganic growth strategies such as acquisitions by key players in the market. For instance, in June, 2018, Agilent Technologies, an American life science company, has acquired privately held ProZyme Inc., a provider of glycan analysis, reagents and kits. This acquisition will help the company expand its glycobiology product portfolio
Key features of the study:
- This report provides in-depth analysis of the global glycobiology market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global glycobiology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Tracxn Technologies Limited, Agilent Tecnologies,Inc., Blirt.eu, Takara Bio Inc., Bio-Techne, Bruker Corporation, Thermo Fisher Scientific Inc., Shimadzu Corporation, New England Biolabs., Waters.co., Merck KGaA, Palleon Pharmaceuticals, Asparia Glycomics, RayBiotech Life, Inc., Z Biotech, LLC., Chemily Glycoscience, Lectenz Bio, 2BScientific , and Glycodiag
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global glycobiology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global glycobiology market
Detailed Segmentation:
- Global Glycobiology Market, By Product Type:
- Instruments
- Enzymes
- Glycosidase
- Heparinase
- Chitinase
- Acetylgalactosaminidase
- PNGase
- Chitobiase
- Others
- GlcNAc Transferases
- Acetylglucosaminyltransferase
- Exostosin
- Others
- GalNAc Transferases
- Polypeptide GalNAc Transferase
- GANLTL
- Others
- Fucosyl Transferases
- Galactosyl Transferases
- Carbohydrate Kinases
- Others
- Consumables
- Reagents & Kits
- Global Glycobiology Market, By Application:
- Diagnostic Application
- Industrial Application
- Therapeutic Application
- Drug Discovery and Development
- Others
- Global Glycobiology Market, By End User:
- Research Laboratories
- Hospitals
- Diagnostic Centres
- Biopharmaceutical Companies
- Others
- Global Glycobiology Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Tracxn Technologies Limited
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Agilent Tecnologies, Inc
- Blirt.eu
- Takara Bio Inc.
- Bio-Techne.
- Bruker Corporation
- Thermo Fisher Scientific Inc
- Shimadzu Corporation
- New England Biolabs.
- Waters.co.
- Merck KGaA
- Palleon Pharmaceuticals
- Asparia Glycomics
- RayBiotech Life, Inc.
- Z Biotech, LLC.
- Chemily Glycoscience
- Lectenz Bio
- 2BScientific
- Glycodiag
- Tracxn Technologies Limited
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Product Launches
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Glycobiology Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact on Healthcare sector
- Impact on Supply and Demand
- COVID-19 Impact on the market
5. Global Glycobiology Market, By Product Type, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Enzymes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Glycosidase
- Heparinase
- Chitinase
- Acetylgalactosaminidase
- PNGase
- Chitobiase
- Others
- GlcNAc Transferases
- Acetylglucosaminyltransferase
- Exostosin
- Other
- GalNAc Transferases
- Polypeptide GalNAc Transferase
- GANLTL
- Others
- Fucosyl Transferases
- Galactosyl Transferases
- Carbohydrate Kinases
- Others
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Reagents & Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global Glycobiology Market, By Application, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Diagnostic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Industrial Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Therapeutic Application
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Drug Discovery and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global Glycobiology Market, By End User, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Diagnostic Centres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
8. Global Glycobiology Market, By Region, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Tracxn Technologies Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Agilent Tecnologies, Inc
- Blirt.eu
- Takara Bio Inc.
- Bio-Techne
- Bruker Corporation
- Thermo Fisher Scientific Inc
- Shimadzu Corporation
- New England Biolabs.
- Waters.co.
- Merck KGaA
- Palleon Pharmaceuticals
- Asparia Glycomics
- RayBiotech Life, Inc
- Z Biotech, LLC
- Chemily Glycoscience
- Lectenz Bio,
- 2BScientific
- Glycodiag
10. Section
- Research Methodology
- About Us
